Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Medicine|July 22, 2022
Dedicated staff for patient education improves bowel preparation quality and reduces the cecal intubation time of colonoscopy: A single institution retrospective studyYu-Tse Chiu, Chen-Ya Kuo, Fu-Jen Lee, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 22, 2025
The impact of glucagon-like peptide-1 receptor agonists on the quality indicators of colonoscopy - a systematic review and meta-analysisYu-Tse Chiu, Yu-Tsung Chen, Fu-Jen Lee, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 19, 2019
Microbiota and gastrointestinal cancerMeng-Tzu Weng, Yu-Tse Chiu, Ping-Ya Wei, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 29, 2018
Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updatesHau-Jyun Su, Yu-Tse Chiu, Chuan-Tai Chiu, et al.JGH Open : an Open Access Journal of Gastroenterology and Hepatology|February 28, 2023
Seven-day vonoprazan-based triple therapy as first-line<i>Helicobacter pylori</i> treatment in comparison with extended sequential therapyYu-Tse Chiu, Fu-Jen Lee, Chen-Ya Kuo, et al.Helicobacter|August 21, 2024
Seven-Day Vonoprazan-Based Triple Therapy as First-Line Helicobacter pylori Treatment in Comparison With Extended Sequential Therapy: A Randomized Controlled TrialYu-Tse Chiu, Fu-Jen Lee, Chen-Ya Kuo, et al.JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 30, 2025
The Post-Cholecystectomy Gut Microbiota Follows a Time-Varying Change-A Pilot StudyYu-Tse Chiu, Fu-Jen Lee, Chen-Ya Kuo, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 2, 2026
Fourteen-day vonoprazan-based dual therapy with amoxicillin as first-line Helicobacter pylori treatment in comparison with sequential therapy: A randomized controlled trialTe-Ling Ma, Chun-Ying Huang, Chen-Ya Kuo, et al.Pageof 1